98 related articles for article (PubMed ID: 20705047)
1. Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death.
Yoon IS; Au Q; Barber JR; Ng SC; Zhang B
Anal Biochem; 2010 Dec; 407(2):205-10. PubMed ID: 20705047
[TBL] [Abstract][Full Text] [Related]
2. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells.
Sánchez-Reus MI; Peinado II; Molina-Jiménez MF; Benedí J
Neurosci Res; 2005 Sep; 53(1):48-56. PubMed ID: 15996779
[TBL] [Abstract][Full Text] [Related]
3. Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity.
de Oliveira DM; Barreto G; Galeano P; Romero JI; Holubiec MI; Badorrey MS; Capani F; Alvarez LD
Hum Exp Toxicol; 2011 Sep; 30(9):1382-91. PubMed ID: 21081703
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
5. High-content image-based screening for small-molecule chaperone amplifiers in heat shock.
Au Q; Kanchanastit P; Barber JR; Ng SC; Zhang B
J Biomol Screen; 2008 Dec; 13(10):953-9. PubMed ID: 19015292
[TBL] [Abstract][Full Text] [Related]
6. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
7. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Tapias V; Cannon JR; Greenamyre JT
J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells.
Molina-Jiménez MF; Sánchez-Reus MI; Andres D; Cascales M; Benedi J
Brain Res; 2004 May; 1009(1-2):9-16. PubMed ID: 15120578
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
10. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
[TBL] [Abstract][Full Text] [Related]
12. Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine.
Molina-Jiménez MF; Sánchez-Reus MI; Cascales M; Andrés D; Benedí J
Toxicol Appl Pharmacol; 2005 Dec; 209(3):214-25. PubMed ID: 15904944
[TBL] [Abstract][Full Text] [Related]
13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster.
Hosamani R; Muralidhara
Neurotoxicology; 2009 Nov; 30(6):977-85. PubMed ID: 19744517
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
Inden M; Kitamura Y; Takeuchi H; Yanagida T; Takata K; Kobayashi Y; Taniguchi T; Yoshimoto K; Kaneko M; Okuma Y; Taira T; Ariga H; Shimohama S
J Neurochem; 2007 Jun; 101(6):1491-1504. PubMed ID: 17459145
[TBL] [Abstract][Full Text] [Related]
16. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
Wang L; Bao Y; Yang Y; Wu Y; Chen X; Si S; Hong B
J Biomol Screen; 2010 Mar; 15(3):239-50. PubMed ID: 20150587
[TBL] [Abstract][Full Text] [Related]
17. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
[TBL] [Abstract][Full Text] [Related]
18. Development of a fluorescent intensity assay amenable for high-throughput screening for determining 15-lipoxygenase activity.
Dahlström M; Forsström D; Johannesson M; Huque-Andersson Y; Björk M; Silfverplatz E; Sanin A; Schaal W; Pelcman B; Forsell PK
J Biomol Screen; 2010 Jul; 15(6):671-9. PubMed ID: 20581078
[TBL] [Abstract][Full Text] [Related]
19. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells.
Lu L; Gu L; Liang Y; Sun X; Duan C; Yang H
Sci China Life Sci; 2010 May; 53(5):590-7. PubMed ID: 20596942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
